$108.16
2.182.06%
À la fermeture: -
$106.09
-2.07-1.91%
Après les heures de négociation: 7:18 PM EDT
Comments
Loading...
Activité de trading des initiés
Suivez les dernières activités de délit d'initié Incyte. Restez informé des achats, des ventes et de l'impact sur le marché des actions Incyte.
Qu’est-ce que l’activité d’initié ?
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Que font les Incyte Corp Insiders ?
À Incyte Corp, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de 3.07K actions d'une valeur de $289.02K. ne signalez aucun achat au cours des 30 derniers jours.
Achats et ventes récents notables d’initiés
- Le novembre 5, 2025 Lee Heeson, le EVP, HEAD INCYTE INTL sold 3.07K actions pour $94.02 chacune.
- Le octobre 6, 2025 Sheila Denton, le EVP & GENERAL COUNSEL sold 6.63K actions pour $72.05 chacune.
Statistiques de propriété pour Incyte Corp
Actions en circulation
196.323M
Actions détenues par les initiés
4.280M
Pourcentage d'actions détenu par les initiés
2.18%
Actions détenues par les institutions
108.240M
Pourcentage d'actions détenu par les institutions
55.1%
Nov 07, 2025 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $97.62 | -$47.94K | SELL-OPTIONS | 0.00% | 102.89K | Nov 05 | ||
Nov 06, 2025 | EVP & GENERAL COUNSEL | 0.00 | $79.71 | -$25.89K | SELL-OPTIONS | 0.00% | 26.57K | Nov 04 | ||
Nov 05, 2025 | EVP, HEAD INCYTE INTL | -3.07K | $94.02 | -$289.02K | SELL | -9.51% | 29.24K | Nov 03 | ||
Oct 17, 2025 | EVP & GENERAL COUNSEL | 0.00 | $74.69 | -$5.78K | SELL-OPTIONS | 0.00% | 26.57K | Oct 15 | ||
Oct 06, 2025 | EVP & GENERAL COUNSEL | -6.63K | $72.05 | -$587.26K | SELL | -19.97% | 26.57K | Oct 02 - Oct 03 | ||
Sep 18, 2025 | EVP & GENERAL COUNSEL | 0.00 | $73.70 | -$5.25K | SELL-OPTIONS | 0.00% | 33.20K | Sep 16 | ||
Sep 04, 2025 | EVP & GENERAL COUNSEL | 0.00 | $71.52 | -$16.09K | SELL-OPTIONS | 0.00% | 33.20K | Sep 02 | ||
Aug 19, 2025 | EVP & GENERAL COUNSEL | 0.00 | $75.53 | -$6.25K | SELL-OPTIONS | 0.00% | 33.20K | Aug 15 | ||
Aug 06, 2025 | EVP & GENERAL COUNSEL | 0.00 | $66.92 | -$10.59K | SELL-OPTIONS | 0.00% | 33.20K | Aug 04 | ||
Jul 23, 2025 | EVP & CHIEF MEDICAL OFFICER | -3.71K | $67.94 | -$251.79K | SELL | -3.48% | 102.89K | Jul 21 | ||
Jul 17, 2025 | EVP & GENERAL MANAGER US | -1.34K | $68.36 | -$91.60K | SELL | -3.67% | 35.15K | Jul 16 | ||
Jul 17, 2025 | EVP, GMAPPS | -983.00 | $68.36 | -$67.20K | SELL | -2.37% | 40.54K | Jul 16 | ||
Jul 17, 2025 | EVP & GENERAL COUNSEL | 6.70K | $66.82 | -$120.32K | SELL-OPTIONS | 25.26% | 33.20K | Jul 15 - Jul 16 | ||
Jul 16, 2025 | EVP & CHIEF MEDICAL OFFICER | -5.83K | $68.58 | -$1.24M | SELL | -5.18% | 106.59K | Jul 14 - Jul 15 | ||
Jul 16, 2025 | EVP, GMAPPS | 3.82K | $69.37 | -$180.92K | GRANT | 10.14% | 41.52K | Jul 14 - Jul 15 | ||
Jul 16, 2025 | EVP & GENERAL MANAGER US | -3.25K | $69.33 | -$225.67K | SELL | -8.19% | 36.49K | Jul 14 - Jul 15 | ||
Jul 07, 2025 | EVP & GENERAL MANAGER US | -19.96K | $68.16 | -$1.36M | SELL | -33.43% | 39.74K | Jul 02 - Jul 03 | ||
Jul 07, 2025 | EVP & GENERAL COUNSEL | 0.00 | $63.34 | -$6.32K | SELL-OPTIONS | 0.00% | 26.50K | Jul 02 | ||
Jul 07, 2025 | EVP, GMAPPS | -15.43K | $68.16 | -$1.05M | SELL | -29.04% | 37.70K | Jul 02 - Jul 03 | ||
Jun 05, 2025 | EVP & GENERAL COUNSEL | 0.00 | $63.03 | -$17.84K | SELL-OPTIONS | 0.00% | 26.50K | Jun 03 | ||
Jun 03, 2025 | PRINCIPAL ACCOUNTING OFFICER | -1.61K | $65.38 | -$105.52K | SELL | -6.83% | 22.00K | May 30 - Jun 02 | ||
Mar 18, 2025 | EVP & GENERAL MANAGER US | -19.81K | $67.69 | -$1.34M | SELL | -37.11% | 33.57K | Mar 14 | ||
Mar 06, 2025 | EVP & GENERAL COUNSEL | 0.00 | $64.03 | -$7.15K | SELL-OPTIONS | 0.00% | 25.85K | Mar 04 | ||
Feb 28, 2025 | EVP & GENERAL COUNSEL | -4.50K | $66.07 | -$486.27K | SELL | -14.81% | 25.85K | Feb 26 | ||
Jan 22, 2025 | EVP & CHIEF MEDICAL OFFICER | -12.35K | $72.69 | -$897.87K | SELL | -15.57% | 66.97K | Jan 21 | ||
Dec 17, 2024 | PRINCIPAL ACCOUNTING OFFICER | -1.30K | $69.97 | -$90.97K | SELL | -5.28% | 23.31K | Dec 13 - Dec 16 | ||
Dec 03, 2024 | EVP, GMAPPS | -6.04K | $75.38 | -$455.54K | SELL | -16.47% | 30.66K | Nov 29 | ||
Nov 08, 2024 | EVP & GENERAL MANAGER US | 0.00 | $74.85 | -$35.49K | SELL-OPTIONS | 0.00% | 58.04K | Nov 06 | ||
Sep 16, 2024 | PRINCIPAL ACCOUNTING OFFICER | -954.00 | $63.11 | -$60.21K | SELL | -3.76% | 24.44K | Sep 12 - Sep 13 | ||
Sep 16, 2024 | EVP, GENERAL MANAGER, EUROPE | -8.45K | $62.36 | -$526.95K | SELL | -18.84% | 36.39K | Sep 12 | ||
Aug 14, 2024 | EVP & CHIEF MEDICAL OFFICER | -11.61K | $60.63 | -$703.79K | SELL | -11.42% | 90.01K | Aug 12 | ||
Jul 29, 2024 | EVP, GMAPPS | -15.57K | $70.00 | -$1.09M | SELL | -29.79% | 36.70K | Jul 25 | ||
Jul 17, 2024 | EVP & GENERAL MANAGER US | 7.51K | $64.22 | -$155.21K | GRANT | 14.86% | 58.04K | Jul 15 - Jul 16 | ||
Jul 11, 2024 | EVP & GENERAL MANAGER US | -8.15K | $60.00 | -$488.88K | SELL | -13.89% | 50.53K | Jul 09 | ||
Jun 14, 2024 | EVP & GENERAL MANAGER US | -19.16K | $60.00 | -$1.15M | SELL | -22.40% | 66.38K | Jun 12 | ||
Jun 10, 2024 | PRINCIPAL ACCOUNTING OFFICER | -1.09K | $58.91 | -$64.39K | SELL | -4.81% | 21.63K | Jun 06 | ||
Jan 05, 2024 | EVP & CHIEF MEDICAL OFFICER | -7.37K | $65.51 | -$482.48K | SELL | -7.55% | 90.22K | Jan 03 | ||
Jan 04, 2024 | EVP, GMAPPS | -657.00 | $65.00 | -$42.70K | SELL | -1.49% | 43.41K | Jan 02 | ||
Dec 14, 2023 | PRINCIPAL ACCOUNTING OFFICER | -1.28K | $61.55 | -$78.59K | SELL | -5.17% | 23.44K | Dec 12 - Dec 13 | ||
Sep 06, 2023 | EVP, HUMAN RESOURCES | -8.45K | $65.13 | -$550.28K | SELL | -9.83% | 77.53K | Sep 01 | ||
Aug 03, 2023 | EVP & CHIEF MEDICAL OFFICER | -21.51K | $63.28 | -$1.36M | SELL | -18.06% | 97.58K | Aug 01 | ||
Feb 02, 2023 | EVP & GENERAL COUNSEL | 0.00 | $79.42 | -$7.44K | SELL-OPTIONS | 0.00% | 68.52K | Jan 31 | ||
Feb 01, 2023 | EVP & GENERAL COUNSEL | 0.00 | $79.07 | -$681.35K | SELL-OPTIONS | 0.00% | 68.52K | Jan 30 | ||
Jan 30, 2023 | EVP, GMAPPS | 0.00 | $76.81 | -$114.66K | SELL-OPTIONS | 0.00% | 42.84K | Jan 26 | ||
Jan 30, 2023 | EVP & CHIEF SCIENTIFIC OFFICER | -2.42K | $85.00 | -$205.62K | SELL | -4.34% | 53.26K | Jan 26 | ||
Jan 06, 2023 | EVP & CHIEF MEDICAL OFFICER | -28.40K | $79.78 | -$2.27M | SELL | -20.67% | 109.02K | Jan 04 | ||
Dec 28, 2022 | EVP, GMAPPS | -2.46K | $75.83 | -$346.28K | SELL | -6.10% | 37.85K | Dec 23 | ||
Dec 21, 2022 | PRINCIPAL ACCOUNTING OFFICER | -1.22K | $82.16 | -$100.48K | SELL | -6.86% | 16.61K | Dec 19 | ||
Jul 26, 2022 | PRINCIPAL ACCOUNTING OFFICER | -1.56K | $83.13 | -$130.02K | SELL | -8.12% | 17.70K | Jul 22 | ||
Jul 11, 2022 | EVP, GMAPPS | -5.79K | $79.38 | -$459.37K | SELL | -12.55% | 40.31K | Jul 07 | ||
Jul 11, 2022 | EVP & GENERAL MANAGER US | -2.87K | $79.38 | -$228.06K | SELL | -3.80% | 72.67K | Jul 07 | ||
Apr 12, 2022 | EVP & GENERAL MANAGER US | -2.13K | $76.98 | -$722.26K | SELL | -3.16% | 65.16K | Apr 08 | ||
Mar 10, 2022 | DIRECTOR | 429.08K | $67.56 | $28.99M | BUY | 1.30% | 33.45M | Mar 08 - Mar 10 | ||
Feb 22, 2022 | DIRECTOR | 525.80K | $67.96 | $35.73M | BUY | 1.62% | 33.07M | Feb 17 - Feb 22 | ||
Feb 14, 2022 | DIRECTOR | 1.60M | $66.91 | $106.95M | BUY | 4.73% | 35.41M | Feb 10 - Feb 14 | ||
Feb 02, 2022 | EVP, GENERAL MANAGER, EUROPE | -7.38K | $74.19 | -$547.15K | SELL | -19.62% | 30.21K | Jan 31 | ||
Jan 11, 2022 | EVP, HUMAN RESOURCES | 0.00 | $73.26 | -$1.09K | SELL-OPTIONS | 0.00% | 72.37K | Jan 07 | ||
Jan 05, 2022 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $73.26 | -$821.40 | SELL-OPTIONS | 0.00% | 32.27K | Jan 03 | ||
Jan 05, 2022 | EVP, HUMAN RESOURCES | 8.68K | $73.33 | -$2.33K | SELL-OPTIONS | 13.62% | 72.37K | Jan 01 - Jan 04 | ||
Dec 27, 2021 | DIRECTOR | 0.00 | $47.65 | $1.02M | SELL-OPTIONS | 0.00% | 17.26K | Dec 23 | ||
Dec 17, 2021 | DIRECTOR | 1.60M | $72.43 | $115.56M | BUY | 5.43% | 30.97M | Dec 15 - Dec 17 | ||
Oct 04, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -389.00 | $68.67 | -$26.71K | SELL | -1.23% | 31.26K | Oct 01 | ||
Sep 03, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -388.00 | $76.71 | -$29.76K | SELL | -1.21% | 31.65K | Sep 01 | ||
Aug 04, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -389.00 | $77.49 | -$30.14K | SELL | -1.20% | 32.04K | Aug 02 | ||
Aug 02, 2021 | EVP GPS, BD, & LICENSING | -4.91K | $78.29 | -$384.48K | SELL | -15.39% | 27.00K | Jul 29 | ||
Jul 02, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -396.00 | $84.09 | -$33.30K | SELL | -1.49% | 26.15K | Jul 01 | ||
Jun 30, 2021 | EVP, HEAD DISCOVERY CHEM | -50.00K | $85.48 | -$4.27M | SELL | -34.70% | 94.08K | Jun 28 - Jun 29 | ||
Jun 14, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $76.21 | -$82.98K | SELL-OPTIONS | 0.00% | 26.55K | Jun 10 | ||
Jun 03, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -395.00 | $84.13 | -$33.23K | SELL | -1.47% | 26.55K | Jun 01 | ||
May 05, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -396.00 | $85.40 | -$33.82K | SELL | -1.45% | 26.94K | May 03 | ||
Apr 05, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -396.00 | $81.57 | -$32.30K | SELL | -1.43% | 27.34K | Apr 01 | ||
Mar 31, 2021 | EVP, HEAD TECH. OPERATIONS | -20.00K | $81.08 | -$1.62M | SELL | -30.56% | 45.45K | Mar 29 | ||
Mar 03, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -395.00 | $79.73 | -$31.49K | SELL | -1.40% | 27.73K | Mar 01 | ||
Feb 23, 2021 | CHAIRMAN / CEO | 12.93K | $77.37 | $1.00M | BUY | 3.83% | 350.46K | Feb 23 | ||
Feb 03, 2021 | EVP & CHIEF SCIENTIFIC OFFICER | -395.00 | $77.71 | -$59.17K | SELL | -1.38% | 28.13K | Feb 01 | ||
Jan 27, 2021 | EVP, HEAD DISCOVERY CHEM | 0.00 | $86.60 | -$577.19K | SELL-OPTIONS | 0.00% | 143.78K | Jan 25 | ||
Jan 27, 2021 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $84.31 | -$119.09K | SELL-OPTIONS | 0.00% | 119.74K | Jan 25 | ||
Jan 27, 2021 | EVP GPS, BD, & LICENSING | -1.00K | $85.93 | -$206.59K | SELL | -3.68% | 26.16K | Jan 25 | ||
Jan 27, 2021 | EVP & GENERAL MANAGER US | -2.74K | $100.00 | -$274.40K | SELL | -5.20% | 49.99K | Jan 25 | ||
Nov 12, 2020 | — | -798.00 | $83.00 | -$66.23K | SELL | -8.45% | 8.65K | Nov 10 | ||
Nov 10, 2020 | — | 0.00 | $75.30 | -$18.98K | OPTION EXERCISE | 0.00% | 28.01K | Nov 06 | ||
Nov 04, 2020 | — | 0.00 | $67.52 | -$763.20K | OPTION EXERCISE | 0.00% | 39.98K | Nov 02 | ||
Oct 13, 2020 | EVP & GENERAL COUNSEL | 128.00 | $81.68 | -$29.17K | SELL-OPTIONS | 0.45% | 28.46K | Oct 09 - Oct 12 | ||
Oct 08, 2020 | — | 0.00 | $78.69 | -$25.51K | OPTION EXERCISE | 0.00% | 28.01K | Oct 06 | ||
Sep 14, 2020 | — | 127.00 | $78.09 | -$47.55K | OPTION EXERCISE | 0.45% | 28.33K | Sep 10 - Sep 11 | ||
Sep 10, 2020 | — | 0.00 | $77.18 | -$22.60K | OPTION EXERCISE | 0.00% | 28.01K | Sep 08 | ||
Aug 31, 2020 | — | 0.00 | $56.74 | -$1.51M | OPTION EXERCISE | 0.00% | 14.24K | Aug 27 | ||
Aug 10, 2020 | — | 0.00 | $81.61 | -$31.12K | OPTION EXERCISE | 0.00% | 28.01K | Aug 06 | ||
Jul 17, 2020 | — | -1.39K | $104.02 | -$144.48K | TAX | -1.43% | 95.47K | Jul 15 - Jul 16 | ||
Jul 08, 2020 | — | -3.60K | $108.06 | -$388.46K | SELL | -12.18% | 25.93K | Jul 07 - Jul 08 | ||
Jul 08, 2020 | — | -3.89K | $99.10 | -$653.06K | OPTION EXERCISE | -3.86% | 96.86K | Jul 07 - Jul 08 | ||
Jul 07, 2020 | — | 4.07K | $85.89 | -$984.37K | GRANT OR AWARD | 2.67% | 156.26K | Jul 02 - Jul 06 | ||
Jul 07, 2020 | — | 2.40K | $91.37 | -$1.52M | GRANT OR AWARD | 2.44% | 100.75K | Jul 02 - Jul 06 | ||
Jul 07, 2020 | — | 25.90K | $91.39 | -$4.71M | GRANT OR AWARD | 8.44% | 332.74K | Jul 02 - Jul 07 | ||
Jul 07, 2020 | — | 5.60K | $85.97 | -$152.09K | GRANT OR AWARD | 28.04% | 25.59K | Jul 02 - Jul 06 | ||
Jun 30, 2020 | — | 0.00 | $83.73 | -$4.76M | OPTION EXERCISE | 0.00% | 306.84K | Jun 26 | ||
Jun 25, 2020 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $87.28 | -$315.56K | SELL-OPTIONS | 0.00% | 21.73K | Jun 23 | ||
Jun 25, 2020 | — | 199.00 | $91.60 | -$147.21 | OPTION EXERCISE | 0.55% | 36.06K | Jun 23 | ||
Jun 23, 2020 | — | 0.00 | $86.13 | -$39.46K | OPTION EXERCISE | 0.00% | 23.66K | Jun 19 | ||
Jun 23, 2020 | — | 0.00 | $88.93 | -$252.81K | OPTION EXERCISE | 0.00% | 24.90K | Jun 19 | ||
Jun 23, 2020 | — | 0.00 | $89.11 | -$228.28K | OPTION EXERCISE | 0.00% | 35.86K | Jun 19 | ||
Jun 23, 2020 | — | -9.00K | $105.31 | -$947.79K | SELL | -29.26% | 21.76K | Jun 22 | ||
Jun 12, 2020 | — | 0.00 | $80.58 | -$100.73K | OPTION EXERCISE | 0.00% | 23.53K | Jun 10 | ||
Jun 10, 2020 | — | 0.00 | $78.65 | -$25.42K | OPTION EXERCISE | 0.00% | 19.99K | Jun 08 | ||
May 28, 2020 | — | 2.57K | $102.55 | $205.10 | GRANT OR AWARD | 0.01% | 29.35M | May 26 - May 28 | ||
May 08, 2020 | — | 0.00 | $81.13 | -$30.19K | OPTION EXERCISE | 0.00% | 19.99K | May 06 | ||
Apr 21, 2020 | — | 0.00 | $82.28 | -$40.52K | OPTION EXERCISE | 0.00% | 21.32K | Apr 17 | ||
Apr 21, 2020 | — | 0.00 | $86.60 | -$176.36K | OPTION EXERCISE | 0.00% | 35.34K | Apr 17 | ||
Apr 20, 2020 | — | 0.00 | $83.97 | -$513.40K | OPTION EXERCISE | 0.00% | 22.90K | Apr 16 - Apr 17 | ||
Apr 15, 2020 | — | -838.00 | $77.57 | -$513.64K | OPTION EXERCISE | -3.53% | 22.90K | Apr 13 - Apr 14 | ||
Apr 08, 2020 | — | -1.84K | $85.00 | -$156.57K | SELL | -7.06% | 24.25K | Apr 06 | ||
Apr 08, 2020 | — | 0.00 | $75.21 | -$75.27K | OPTION EXERCISE | 0.00% | 19.99K | Apr 06 | ||
Apr 02, 2020 | — | 0.00 | $68.00 | -$16.05K | OPTION EXERCISE | 0.00% | 48.49K | Mar 31 | ||
Feb 21, 2020 | — | 0.00 | $72.28 | -$38.63K | OPTION EXERCISE | 0.00% | 48.49K | Feb 19 | ||
Feb 07, 2020 | — | 0.00 | $47.14 | -$1.01M | OPTION EXERCISE | 0.00% | 95.31K | Feb 05 | ||
Jan 17, 2020 | — | 0.00 | $72.84 | -$41.42K | OPTION EXERCISE | 0.00% | 41.61K | Jan 15 | ||
Dec 18, 2019 | EVP, HUMAN RESOURCES | 0.00 | $78.08 | -$67.65K | SELL-OPTIONS | 0.00% | 41.61K | Dec 16 | ||
Dec 03, 2019 | EVP, HEAD DISCOVERY CHEM | 0.00 | $56.66 | -$1.53M | SELL-OPTIONS | 0.00% | 95.31K | Nov 29 - Dec 02 | ||
Dec 03, 2019 | EVP GPS, BD, & LICENSING | 0.00 | $83.93 | -$174.15K | SELL-OPTIONS | 0.00% | 17.61K | Nov 29 - Dec 02 | ||
Dec 03, 2019 | EVP & GENERAL MANAGER US | 0.00 | $84.10 | -$156.50K | SELL-OPTIONS | 0.00% | 16.98K | Nov 29 - Dec 02 | ||
Nov 26, 2019 | EVP & GENERAL MANAGER US | 0.00 | $69.22 | -$89.02K | SELL-OPTIONS | 0.00% | 16.98K | Nov 25 | ||
Nov 26, 2019 | EVP, HEAD DISCOVERY CHEM | 0.00 | $54.16 | -$1.08M | SELL-OPTIONS | 0.00% | 95.31K | Nov 25 | ||
Nov 26, 2019 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $54.16 | -$1.08M | SELL-OPTIONS | 0.00% | 17.31K | Nov 25 | ||
Nov 19, 2019 | EVP, HUMAN RESOURCES | 0.00 | $75.50 | -$54.77K | SELL-OPTIONS | 0.00% | 41.61K | Nov 15 | ||
Nov 08, 2019 | DIRECTOR | 0.00 | $48.19 | -$3.81M | SELL-OPTIONS | 0.00% | 12.34K | Nov 06 - Nov 08 | ||
Nov 05, 2019 | EVP, HEAD DISCOVERY CHEM | 0.00 | $51.66 | -$530.77K | SELL-OPTIONS | 0.00% | 95.31K | Nov 01 | ||
Nov 05, 2019 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $51.66 | -$566.78K | SELL-OPTIONS | 0.00% | 17.31K | Nov 01 | ||
Oct 31, 2019 | EVP, HEAD DISCOVERY CHEM | -50.00K | $51.66 | -$136.03K | SELL | -34.41% | 95.31K | Oct 29 - Oct 30 | ||
Oct 31, 2019 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $49.39 | -$1.03M | SELL-OPTIONS | 0.00% | 17.31K | Oct 29 | ||
Oct 31, 2019 | EVP GPS, BD, & LICENSING | -930.00 | $85.00 | -$79.05K | SELL | -5.02% | 17.61K | Oct 29 | ||
Oct 24, 2019 | EVP, HUMAN RESOURCES | 0.00 | $72.28 | -$38.63K | SELL-OPTIONS | 0.00% | 41.61K | Oct 22 | ||
Sep 19, 2019 | EVP, HUMAN RESOURCES | 0.00 | $72.28 | -$38.63K | SELL-OPTIONS | 0.00% | 41.61K | Sep 18 | ||
Sep 19, 2019 | EVP & GENERAL MANAGER US | -2.49K | $77.71 | -$193.58K | SELL | -12.94% | 16.76K | Sep 17 | ||
Aug 19, 2019 | EVP, HUMAN RESOURCES | 0.00 | $72.75 | -$41.02K | SELL-OPTIONS | 0.00% | 41.61K | Aug 15 | ||
Aug 06, 2019 | DIRECTOR | 0.00 | $50.50 | -$6.44M | SELL-OPTIONS | 0.00% | 270.53K | Aug 02 - Aug 06 | ||
Aug 05, 2019 | DIRECTOR | -1.72K | $85.07 | -$146.65K | SELL | -19.64% | 7.05K | Aug 01 - Aug 02 | ||
Jul 18, 2019 | EVP & GENERAL MANAGER US | -959.00 | $79.91 | -$76.63K | SELL | -4.75% | 19.25K | Jul 17 | ||
Jul 16, 2019 | EVP, HUMAN RESOURCES | -639.00 | $72.42 | -$90.63K | SELL | -1.51% | 41.61K | Jul 15 | ||
Jun 25, 2019 | EVP & CHIEF MEDICAL OFFICER | -8.36K | $87.96 | -$735.08K | SELL | -43.61% | 10.80K | Jun 24 | ||
Jun 18, 2019 | EVP, HUMAN RESOURCES | 0.00 | $72.28 | -$38.63K | SELL-OPTIONS | 0.00% | 36.51K | Jun 17 | ||
Apr 02, 2019 | EVP, HUMAN RESOURCES | 0.00 | $52.67 | -$686.90K | SELL-OPTIONS | 0.00% | 36.51K | Apr 01 | ||
Mar 05, 2019 | EVP, HUMAN RESOURCES | 0.00 | $52.50 | -$683.60K | SELL-OPTIONS | 0.00% | 36.51K | Mar 01 | ||
Feb 05, 2019 | EVP, HUMAN RESOURCES | 0.00 | $49.75 | -$628.70K | SELL-OPTIONS | 0.00% | 31.12K | Feb 01 | ||
Jan 30, 2019 | EVP & GENERAL MANAGER US | -1.00K | $80.00 | -$80.00K | SELL | -10.06% | 8.94K | Jan 28 | ||
Jan 22, 2019 | EVP, HEAD DISCOVERY CHEM | 0.00 | $47.70 | -$918.48K | SELL-OPTIONS | 0.00% | 34.41K | Jan 17 | ||
Jan 17, 2019 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $46.39 | -$332.56K | SELL-OPTIONS | 0.00% | 13.90K | Jan 15 | ||
Jan 10, 2019 | EVP & GENERAL MANAGER US | -1.71K | $75.56 | -$129.51K | SELL | -14.70% | 9.94K | Jan 08 | ||
Jan 08, 2019 | EVP, HEAD DISCOVERY CHEM | -808.00 | $46.37 | -$632.06K | SELL | -2.29% | 34.41K | Jan 07 | ||
Jan 08, 2019 | PRINCIPAL ACCOUNTING OFFICER | -272.00 | $46.38 | -$545.77K | SELL | -1.92% | 13.90K | Jan 07 | ||
Jan 08, 2019 | EVP, HUMAN RESOURCES | -1.20K | $44.24 | -$1.64M | SELL | -3.71% | 31.12K | Jan 04 - Jan 07 | ||
Nov 09, 2018 | DIRECTOR | 1.00K | $68.77 | $68.77K | BUY | 17.64% | 6.67K | Nov 08 | ||
Oct 05, 2018 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $43.89 | -$522.10K | SELL-OPTIONS | 0.00% | 14.17K | Oct 03 | ||
Oct 05, 2018 | EVP, HUMAN RESOURCES | 0.00 | $44.16 | -$516.80K | SELL-OPTIONS | 0.00% | 32.32K | Oct 03 | ||
Oct 05, 2018 | EVP & GENERAL MANAGER US | -1.00K | $70.00 | -$70.00K | SELL | -7.45% | 12.43K | Oct 03 | ||
Sep 06, 2018 | EVP, HUMAN RESOURCES | 0.00 | $45.77 | -$548.90K | SELL-OPTIONS | 0.00% | 32.32K | Sep 04 | ||
Aug 22, 2018 | EVP, HUMAN RESOURCES | 0.00 | $44.16 | -$516.80K | SELL-OPTIONS | 0.00% | 32.32K | Aug 21 | ||
Jul 11, 2018 | EVP, HUMAN RESOURCES | 0.00 | $44.72 | -$527.90K | SELL-OPTIONS | 0.00% | 32.96K | Jul 09 | ||
Jul 11, 2018 | EVP GPS, BD, & LICENSING | -606.00 | $71.34 | -$43.23K | SELL | -6.96% | 8.10K | Jul 09 | ||
May 03, 2018 | CHAIRMAN / CEO | 15.00K | $60.94 | $914.10K | BUY | 5.73% | 276.69K | May 02 | ||
May 02, 2018 | EVP, HUMAN RESOURCES | 0.00 | $40.11 | -$3.57M | SELL-OPTIONS | 0.00% | 33.37K | Apr 30 | ||
Feb 22, 2018 | EXECUTIVE VICE PRESIDENT, CFO | -3.02K | $85.73 | -$259.07K | SELL | -21.60% | 10.97K | Feb 20 - Feb 21 | ||
Feb 22, 2018 | EVP, CHIEF SCIENTIFIC OFFICER | -3.02K | $85.72 | -$259.04K | SELL | -7.91% | 35.18K | Feb 20 - Feb 21 | ||
Jan 09, 2018 | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $91.35 | -$101.67K | SELL-OPTIONS | 0.00% | 13.99K | Jan 05 | ||
Jan 03, 2018 | EVP GPS, BD, & LICENSING | 0.00 | $85.06 | -$122.00K | SELL-OPTIONS | 0.00% | 8.68K | Jan 02 | ||
Dec 05, 2017 | EVP, CHIEF SCIENTIFIC OFFICER | -696.00 | $98.01 | -$68.21K | SELL | -1.79% | 38.20K | Dec 01 | ||
Nov 20, 2017 | DIRECTOR | -28.51K | $105.24 | -$3.00M | SELL | -9.58% | 269.01K | Nov 16 | ||
Nov 03, 2017 | EXECUTIVE VICE PRESIDENT, CFO | -7.83K | $106.79 | -$835.99K | SELL | -35.88% | 13.99K | Nov 01 - Nov 02 | ||
Sep 20, 2017 | CHAIRMAN / CEO | -70.50K | $119.45 | -$8.42M | SELL | -19.08% | 299.00K | Sep 18 | ||
Sep 15, 2017 | EVP & GENERAL MANAGER US | -1.39K | $123.72 | -$171.72K | SELL | -8.58% | 14.78K | Sep 13 - Sep 14 | ||
Sep 08, 2017 | DIRECTOR | 100.00K | $132.00 | $13.20M | BUY | 13.83% | 822.83K | Sep 08 | ||
Sep 07, 2017 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $78.10 | -$361.86K | SELL-OPTIONS | 0.00% | 11.85K | Sep 05 | ||
Sep 05, 2017 | EVP, GENERAL COUNSEL | 0.00 | $100.97 | -$132.59K | SELL-OPTIONS | 0.00% | 21.73K | Sep 01 | ||
Sep 05, 2017 | EVP, HUMAN RESOURCES | 0.00 | $78.89 | -$2.44M | SELL-OPTIONS | 0.00% | 35.07K | Aug 31 | ||
Aug 31, 2017 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $107.26 | -$74.90K | SELL-OPTIONS | 0.00% | 18.16K | Aug 29 | ||
Aug 07, 2017 | PRINCIPAL ACCOUNTING OFFICER | -295.00 | $71.55 | -$359.54K | SELL | -2.43% | 11.85K | Aug 03 - Aug 04 | ||
Aug 03, 2017 | EVP, GENERAL COUNSEL | 0.00 | $98.73 | -$124.43K | SELL-OPTIONS | 0.00% | 21.73K | Aug 01 | ||
Jul 21, 2017 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $108.39 | -$294.48K | SELL-OPTIONS | 0.00% | 18.16K | Jul 20 | ||
Jul 07, 2017 | PRINCIPAL ACCOUNTING OFFICER | 1.20K | $71.98 | -$325.17K | SELL-OPTIONS | 10.94% | 12.15K | Jul 05 | ||
Jul 05, 2017 | EVP, GENERAL COUNSEL | 0.00 | $95.38 | -$112.20K | SELL-OPTIONS | 0.00% | 18.22K | Jul 03 | ||
Jul 05, 2017 | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $101.47 | -$33.86K | SELL-OPTIONS | 0.00% | 19.02K | Jun 30 | ||
Jun 22, 2017 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $108.23 | -$331.55K | SELL-OPTIONS | 0.00% | 14.65K | Jun 20 | ||
Jun 14, 2017 | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $94.91 | -$727.04K | SELL-OPTIONS | 0.00% | 19.02K | Jun 12 | ||
Jun 07, 2017 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $75.14 | -$344.13K | SELL-OPTIONS | 0.00% | 10.95K | Jun 05 | ||
Jun 02, 2017 | EVP, GENERAL COUNSEL | 0.00 | $97.28 | -$119.12K | SELL-OPTIONS | 0.00% | 16.92K | Jun 01 | ||
Jun 02, 2017 | DIRECTOR | 500.00 | $131.80 | $65.90K | BUY | 11.97% | 4.68K | May 31 | ||
May 17, 2017 | DIRECTOR | 500.00 | $115.00 | $57.50K | BUY | 13.60% | 4.18K | May 15 | ||
May 09, 2017 | EVP, CHIEF SCIENTIFIC OFFICER | -16.31K | $121.96 | -$1.99M | SELL | -31.16% | 36.04K | May 05 - May 08 | ||
May 09, 2017 | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $69.75 | -$311.73K | SELL-OPTIONS | 0.00% | 10.95K | May 05 | ||
May 02, 2017 | EVP & GENERAL MANAGER US | -3.23K | $86.58 | -$560.58K | SELL | -20.35% | 12.65K | May 01 | ||
May 02, 2017 | EVP, GENERAL COUNSEL | 0.00 | $94.64 | -$109.53K | SELL-OPTIONS | 0.00% | 16.92K | May 01 | ||
May 02, 2017 | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $95.66 | -$79.45K | SELL-OPTIONS | 0.00% | 19.02K | Apr 28 | ||
May 02, 2017 | DIRECTOR | 500.00 | $124.26 | $62.13K | BUY | 15.74% | 3.68K | Apr 28 | ||
Apr 17, 2017 | DIRECTOR | 1.00K | $139.66 | $139.66K | BUY | 45.93% | 3.18K | Apr 13 | ||
Apr 11, 2017 | EVP & CHIEF MEDICAL OFFICER | 0.00 | $113.84 | -$1.54M | SELL-OPTIONS | 0.00% | 14.65K | Apr 07 | ||
Apr 11, 2017 | EVP, GENERAL COUNSEL | 0.00 | $89.66 | -$408.54K | SELL-OPTIONS | 0.00% | 16.79K | Apr 10 | ||
Apr 11, 2017 | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $102.53 | -$2.95M | SELL-OPTIONS | 0.00% | 19.02K | Apr 10 | ||
Apr 11, 2017 | DIRECTOR | 1.00K | $139.48 | $139.48K | BUY | 84.96% | 2.18K | Apr 07 | ||
Mar 20, 2017 | DIRECTOR | 0.00 | $77.50 | -$2.81M | SELL-OPTIONS | 0.00% | 196.76K | Mar 17 | ||
Mar 20, 2017 | DIRECTOR | 0.00 | $83.52 | -$6.52M | SELL-OPTIONS | 0.00% | 297.52K | Mar 16 - Mar 17 | ||
Mar 01, 2017 | EVP, CHIEF SCIENTIFIC OFFICER | -2.01K | $131.88 | -$264.82K | SELL | -3.70% | 52.26K | Feb 27 | ||
Feb 27, 2017 | DIRECTOR | 0.00 | $69.32 | -$5.10M | SELL-OPTIONS | 0.00% | 297.52K | Feb 23 | ||
Jan 11, 2017 | EVP, CHIEF SCIENTIFIC OFFICER | -11.74K | $113.55 | -$1.33M | SELL | -18.36% | 52.19K | Jan 09 | ||
Nov 17, 2016 | EVP, HUMAN RESOURCES | 0.00 | $58.99 | -$885.40K | SELL-OPTIONS | 0.00% | 29.25K | Nov 15 | ||
Nov 10, 2016 | EVP, CHIEF SCIENTIFIC OFFICER | -2.71K | $109.95 | -$298.51K | SELL | -4.07% | 63.92K | Nov 09 | ||
Oct 24, 2016 | EVP, HUMAN RESOURCES | 0.00 | $52.36 | -$752.80K | SELL-OPTIONS | 0.00% | 29.25K | Oct 20 | ||
Oct 11, 2016 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $57.36 | -$914.24K | SELL-OPTIONS | 0.00% | 66.60K | Oct 07 | ||
Oct 11, 2016 | EVP & GENERAL MANAGER US | 0.00 | $72.72 | -$1.18M | SELL-OPTIONS | 0.00% | 11.19K | Oct 07 | ||
Sep 26, 2016 | EVP, HUMAN RESOURCES | 0.00 | $52.36 | -$1.51M | SELL-OPTIONS | 0.00% | 29.25K | Sep 23 | ||
Aug 02, 2016 | EVP, CHIEF SCIENTIFIC OFFICER | -10.00K | $87.96 | -$879.60K | SELL | -13.05% | 66.60K | Aug 02 | ||
Aug 02, 2016 | EVP, HUMAN RESOURCES | 0.00 | $52.36 | -$4.52M | SELL-OPTIONS | 0.00% | 29.25K | Jul 29 | ||
Mar 17, 2016 | DIRECTOR | 860.00K | $59.79 | $51.42M | BUY | 4.43% | 20.27M | Mar 15 - Mar 17 | ||
Feb 26, 2016 | DIRECTOR | 64.29K | $70.79 | $4.55M | BUY | 0.33% | 19.53M | Feb 24 - Feb 25 | ||
Feb 16, 2016 | DIRECTOR | 887.16K | $69.87 | $61.98M | BUY | 4.77% | 19.47M | Feb 12 - Feb 16 | ||
Feb 16, 2016 | DIRECTOR | 2.25M | $63.53 | $143.03M | BUY | 13.71% | 18.67M | Feb 11 - Feb 12 | ||
Jan 20, 2016 | EVP, HUMAN RESOURCES | 0.00 | $40.03 | -$999.26K | SELL-OPTIONS | 0.00% | 23.69K | Jan 15 | ||
Jan 08, 2016 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $60.09 | -$328.90K | SELL-OPTIONS | 0.00% | 16.93K | Jan 06 | ||
Dec 14, 2015 | EVP, GENERAL COUNSEL | 0.00 | $63.14 | -$173.54K | SELL-OPTIONS | 0.00% | 3.71K | Dec 10 | ||
Dec 09, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.25 | -$345.90K | SELL-OPTIONS | 0.00% | 16.93K | Dec 07 | ||
Nov 19, 2015 | DIRECTOR | 0.00 | $65.81 | -$21.61M | SELL-OPTIONS | 0.00% | 297.52K | Nov 17 - Nov 18 | ||
Nov 12, 2015 | EVP, GENERAL COUNSEL | 0.00 | $61.59 | -$192.29K | SELL-OPTIONS | 0.00% | 3.71K | Nov 10 | ||
Nov 10, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $67.42 | -$386.48K | SELL-OPTIONS | 0.00% | 16.93K | Nov 06 | ||
Nov 05, 2015 | EVP, DISCOVERY MEDICINAL AND P | -786.00 | $71.28 | -$633.01K | SELL | -3.55% | 21.37K | Nov 03 | ||
Oct 15, 2015 | EVP, GENERAL COUNSEL | 0.00 | $59.91 | -$184.80K | SELL-OPTIONS | 0.00% | 3.35K | Oct 13 | ||
Oct 08, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $70.31 | -$409.33K | SELL-OPTIONS | 0.00% | 16.93K | Oct 06 | ||
Sep 23, 2015 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $71.31 | -$1.06M | SELL-OPTIONS | 0.00% | 62.87K | Sep 21 | ||
Sep 18, 2015 | EVP, GENERAL COUNSEL | 0.00 | $74.50 | -$249.69K | SELL-OPTIONS | 0.00% | 3.35K | Sep 16 | ||
Sep 15, 2015 | EVP, CHIEF DRUG DEV OFFICER | -4.30K | $130.00 | -$559.13K | SELL | -20.26% | 16.93K | Sep 11 | ||
Sep 10, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $68.61 | -$395.98K | SELL-OPTIONS | 0.00% | 21.23K | Sep 08 | ||
Aug 17, 2015 | EVP, GENERAL COUNSEL | 0.00 | $63.01 | -$198.58K | SELL-OPTIONS | 0.00% | 3.35K | Aug 13 | ||
Aug 10, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $65.14 | -$368.53K | SELL-OPTIONS | 0.00% | 21.23K | Aug 06 | ||
Jul 16, 2015 | EVP, DISCOVERY MEDICINAL AND P | 0.00 | $66.31 | -$1.30M | SELL-OPTIONS | 0.00% | 21.54K | Jul 14 - Jul 15 | ||
Jul 16, 2015 | EVP, GENERAL COUNSEL | 0.00 | $65.97 | -$211.73K | SELL-OPTIONS | 0.00% | 3.35K | Jul 14 | ||
Jul 16, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $68.89 | -$7.18M | SELL-OPTIONS | 0.00% | 21.23K | Jul 15 | ||
Jul 08, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.66 | -$349.13K | SELL-OPTIONS | 0.00% | 21.23K | Jul 06 | ||
Jun 25, 2015 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $64.64 | -$1.02M | SELL-OPTIONS | 0.00% | 3.52K | Jun 23 | ||
Jun 23, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.96 | -$1.81M | SELL-OPTIONS | 0.00% | 21.23K | Jun 19 | ||
Jun 16, 2015 | EVP, GENERAL COUNSEL | 0.00 | $61.81 | -$193.38K | SELL-OPTIONS | 0.00% | 3.35K | Jun 12 | ||
Jun 10, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.95 | -$351.42K | SELL-OPTIONS | 0.00% | 21.23K | Jun 08 | ||
May 28, 2015 | DIRECTOR | 0.00 | $60.97 | -$18.20M | SELL-OPTIONS | 0.00% | 297.52K | May 26 - May 27 | ||
May 28, 2015 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $63.65 | -$1.03M | SELL-OPTIONS | 0.00% | 3.52K | May 26 | ||
May 26, 2015 | DIRECTOR | 0.00 | $61.47 | -$9.56M | SELL-OPTIONS | 0.00% | 297.52K | May 21 - May 22 | ||
May 15, 2015 | EVP, GENERAL COUNSEL | 0.00 | $61.66 | -$192.58K | SELL-OPTIONS | 0.00% | 3.35K | May 14 | ||
May 08, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $58.88 | -$601.19K | SELL-OPTIONS | 0.00% | 21.23K | May 06 | ||
Apr 24, 2015 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $71.82 | -$2.65M | SELL-OPTIONS | 0.00% | 3.52K | Apr 23 | ||
Apr 21, 2015 | EVP, DISCOVERY MEDICINAL AND P | -7.15K | $102.04 | -$729.59K | SELL | -24.92% | 21.54K | Apr 17 | ||
Apr 16, 2015 | EVP, GENERAL COUNSEL | 0.00 | $58.52 | -$178.65K | SELL-OPTIONS | 0.00% | 3.35K | Apr 14 | ||
Apr 14, 2015 | EVP, HUMAN RESOURCES | 0.00 | $49.70 | -$1.53M | SELL-OPTIONS | 0.00% | 21.08K | Apr 13 | ||
Apr 14, 2015 | EVP, DISCOVERY MEDICINAL AND P | 0.00 | $56.49 | -$1.78M | SELL-OPTIONS | 0.00% | 28.69K | Apr 10 - Apr 13 | ||
Apr 08, 2015 | EVP, DISCOVERY MEDICINAL AND P | -15.03K | $53.96 | -$1.72M | SELL | -34.38% | 28.69K | Apr 07 | ||
Apr 08, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $53.55 | -$1.76M | SELL-OPTIONS | 0.00% | 21.23K | Apr 06 | ||
Apr 01, 2015 | — | 0.00 | $55.12 | -$8.76M | SELL-OPTIONS | 0.00% | 2.90K | Mar 30 | ||
Apr 01, 2015 | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $55.86 | -$2.59M | SELL-OPTIONS | 0.00% | 44.41K | Mar 30 | ||
Mar 18, 2015 | EVP, HUMAN RESOURCES | 0.00 | $46.54 | -$1.52M | SELL-OPTIONS | 0.00% | 21.08K | Mar 16 | ||
Mar 13, 2015 | DIRECTOR | 0.00 | $47.61 | -$6.66M | SELL-OPTIONS | 0.00% | 45.83K | Mar 12 | ||
Mar 13, 2015 | EVP, GENERAL COUNSEL | 0.00 | $54.02 | -$158.64K | SELL-OPTIONS | 0.00% | 3.35K | Mar 12 | ||
Mar 10, 2015 | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $54.11 | -$1.79M | SELL-OPTIONS | 0.00% | 21.23K | Mar 06 | ||
Mar 09, 2015 | EVP, GENERAL COUNSEL | 0.00 | $54.16 | -$955.71K | SELL-OPTIONS | 0.00% | 3.35K | Mar 05 | ||
Mar 09, 2015 | DIRECTOR | 0.00 | $54.12 | -$3.04M | SELL-OPTIONS | 0.00% | 92.29K | Mar 05 | ||
Feb 25, 2015 | EVP, GENERAL COUNSEL | 0.00 | $51.66 | -$889.04K | SELL-OPTIONS | 0.00% | 3.35K | Feb 25 | ||
Feb 25, 2015 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $49.62 | -$723.86K | SELL-OPTIONS | 0.00% | 3.52K | Feb 23 - Feb 24 | ||
Feb 20, 2015 | DIRECTOR | 0.00 | $43.06 | -$1.42M | SELL-OPTIONS | 0.00% | 45.83K | Feb 18 | ||
Feb 18, 2015 | DIRECTOR | -120.00K | $74.32 | -$8.92M | SELL | -28.74% | 297.52K | Feb 13 | ||
Feb 18, 2015 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $46.28 | -$734.85K | SELL-OPTIONS | 0.00% | 18.20K | Feb 17 | ||
Feb 18, 2015 | EVP, HUMAN RESOURCES | 0.00 | $40.01 | -$1.29M | SELL-OPTIONS | 0.00% | 21.08K | Feb 17 | ||
Feb 10, 2015 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $46.72 | -$1.42M | SELL-OPTIONS | 0.00% | 18.20K | Feb 06 | ||
Jan 26, 2015 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $47.36 | -$673.59K | SELL-OPTIONS | 0.00% | 3.52K | Jan 23 | ||
Jan 26, 2015 | EVP, GENERAL COUNSEL | 0.00 | $48.82 | -$840.35K | SELL-OPTIONS | 0.00% | 3.35K | Jan 22 - Jan 26 | ||
Jan 20, 2015 | EVP, HUMAN RESOURCES | 0.00 | $38.64 | -$1.24M | SELL-OPTIONS | 0.00% | 21.08K | Jan 20 | ||
Jan 20, 2015 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $43.89 | -$700.20K | SELL-OPTIONS | 0.00% | 18.20K | Jan 16 | ||
Jan 12, 2015 | EVP, GENERAL COUNSEL | 0.00 | $45.89 | -$909.76K | SELL-OPTIONS | 0.00% | 3.35K | Jan 08 | ||
Jan 08, 2015 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $45.08 | -$1.34M | SELL-OPTIONS | 0.00% | 18.20K | Jan 06 | ||
Jan 07, 2015 | EVP, HUMAN RESOURCES | 0.00 | $38.51 | -$1.24M | SELL-OPTIONS | 0.00% | 18.06K | Jan 05 | ||
Dec 29, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $45.74 | -$637.72K | SELL-OPTIONS | 0.00% | 0.00 | Dec 23 | ||
Dec 18, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $43.54 | -$691.68K | SELL-OPTIONS | 0.00% | 18.20K | Dec 16 | ||
Dec 03, 2014 | DIRECTOR | -50.00K | $74.89 | -$3.74M | SELL | -32.26% | 105.00K | Dec 01 - Dec 02 | ||
Nov 26, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $45.56 | -$633.72K | SELL-OPTIONS | 0.00% | 0.00 | Nov 24 | ||
Nov 19, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $42.34 | -$663.00K | SELL-OPTIONS | 0.00% | 18.20K | Nov 17 | ||
Nov 07, 2014 | DIRECTOR | 0.00 | $38.95 | -$10.74M | SELL-OPTIONS | 0.00% | 417.52K | Nov 06 | ||
Oct 24, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $35.27 | -$404.94K | SELL-OPTIONS | 0.00% | 0.00 | Oct 23 | ||
Oct 20, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $31.88 | -$274.48K | SELL-OPTIONS | 0.00% | 4.30K | Oct 16 | ||
Sep 25, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.35 | -$340.05K | SELL-OPTIONS | 0.00% | 0.00 | Sep 23 | ||
Sep 18, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $31.15 | -$262.88K | SELL-OPTIONS | 0.00% | 4.30K | Sep 16 | ||
Aug 27, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $34.50 | -$387.94K | SELL-OPTIONS | 0.00% | 0.00 | Aug 25 | ||
Aug 19, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $33.34 | -$298.00K | SELL-OPTIONS | 0.00% | 4.30K | Aug 18 | ||
Jul 25, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.79 | -$349.94K | SELL-OPTIONS | 0.00% | 0.00 | Jul 23 | ||
Jul 18, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $31.43 | -$267.44K | SELL-OPTIONS | 0.00% | 4.30K | Jul 16 | ||
Jun 25, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $36.54 | -$433.22K | SELL-OPTIONS | 0.00% | 0.00 | Jun 23 | ||
Jun 18, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $34.30 | -$313.28K | SELL-OPTIONS | 0.00% | 4.30K | Jun 16 | ||
Jun 06, 2014 | CHIEF FINANCIAL OFFICER | 0.00 | $30.58 | -$8.86M | SELL-OPTIONS | 0.00% | 8.50K | Jun 04 - Jun 05 | ||
May 28, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.76 | -$349.27K | SELL-OPTIONS | 0.00% | 0.00 | May 23 | ||
May 20, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $32.70 | -$287.68K | SELL-OPTIONS | 0.00% | 4.30K | May 16 | ||
May 14, 2014 | — | -2.06K | $54.00 | -$111.13K | SELL | -54.00% | 1.75K | May 12 | ||
May 06, 2014 | — | 0.00 | $30.48 | -$1.43M | SELL-OPTIONS | 0.00% | 3.81K | May 02 | ||
Apr 25, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.32 | -$940.51K | SELL-OPTIONS | 0.00% | 0.00 | Apr 23 | ||
Feb 21, 2014 | DIRECTOR | 0.00 | $33.31 | -$2.01M | SELL-OPTIONS | 0.00% | 417.52K | Feb 20 | ||
Feb 19, 2014 | DIRECTOR | 0.00 | $37.21 | -$2.83M | SELL-OPTIONS | 0.00% | 155.00K | Feb 18 - Feb 19 | ||
Feb 19, 2014 | DIRECTOR | 0.00 | $36.65 | -$44.72M | SELL-OPTIONS | 0.00% | 417.52K | Feb 14 - Feb 19 | ||
Feb 18, 2014 | DIRECTOR | 0.00 | $36.75 | -$594.70K | SELL-OPTIONS | 0.00% | 45.83K | Feb 13 | ||
Feb 18, 2014 | EVP, HUMAN RESOURCES | 0.00 | $38.64 | -$12.19M | SELL-OPTIONS | 0.00% | 18.06K | Feb 13 | ||
Feb 18, 2014 | EVP, GENERAL COUNSEL | -1.19K | $41.97 | -$2.79M | SELL | -100.00% | 0.00 | Feb 13 | ||
Feb 18, 2014 | — | 0.00 | $37.76 | -$5.61M | SELL-OPTIONS | 0.00% | 3.19K | Feb 13 | ||
Feb 18, 2014 | CHIEF FINANCIAL OFFICER | 0.00 | $39.43 | -$14.54M | SELL-OPTIONS | 0.00% | 8.50K | Feb 13 - Feb 18 | ||
Feb 18, 2014 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $37.56 | -$13.30M | SELL-OPTIONS | 0.00% | 4.30K | Feb 13 - Feb 14 | ||
Feb 18, 2014 | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $41.73 | -$7.84M | SELL-OPTIONS | 0.00% | 0.00 | Feb 13 | ||
Nov 20, 2013 | DIRECTOR | -50.00K | $47.37 | -$2.37M | SELL | -7.45% | 621.08K | Nov 18 | ||
Sep 12, 2013 | CHIEF EXECUTIVE OFFICER | 0.00 | $22.59 | -$11.10M | SELL-OPTIONS | 0.00% | 391.87K | Sep 10 | ||
Sep 09, 2013 | — | -3.03K | $22.94 | -$1.32M | SELL | -60.00% | 2.02K | Sep 05 - Sep 09 | ||
Sep 09, 2013 | EVP, HUMAN RESOURCES | 0.00 | $21.08 | -$2.64M | SELL-OPTIONS | 0.00% | 18.06K | Sep 05 | ||
Sep 09, 2013 | CHIEF FINANCIAL OFFICER | 0.00 | $21.13 | -$2.81M | SELL-OPTIONS | 0.00% | 8.50K | Sep 06 | ||
Sep 09, 2013 | EVP, GENERAL COUNSEL | 0.00 | $26.06 | -$1.02M | SELL-OPTIONS | 0.00% | 899.00 | Sep 06 | ||
Sep 09, 2013 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $23.63 | -$582.50K | SELL-OPTIONS | 0.00% | 0.00 | Sep 06 | ||
Aug 20, 2013 | DIRECTOR | -50.00K | $26.70 | -$1.33M | SELL | -6.93% | 671.08K | Aug 19 | ||
May 21, 2013 | DIRECTOR | -40.00K | $23.08 | -$923.20K | SELL | -5.26% | 721.08K | May 17 | ||
May 15, 2013 | EVP, CHIEF DRUG DEV&MEDICAL OF | 4.30K | $14.70 | -$816.69K | SELL-OPTIONS | ∞ | 4.30K | May 13 | ||
Mar 18, 2013 | DIRECTOR | -10.00K | $25.08 | -$250.80K | SELL | -1.30% | 761.08K | Mar 14 | ||
Mar 05, 2013 | DIRECTOR | -10.00K | $22.56 | -$225.60K | SELL | -1.28% | 771.08K | Mar 01 | ||
Mar 01, 2013 | EVP, GENERAL COUNSEL | 0.00 | $18.91 | -$325.09K | SELL-OPTIONS | 0.00% | 280.00 | Feb 28 | ||
Feb 22, 2013 | EVP, HUMAN RESOURCES | 206.57K | $13.76 | $2.84M | SELL-OPTIONS | ∞ | 18.06K | Feb 20 | ||
Feb 20, 2013 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $14.66 | -$1.54M | SELL-OPTIONS | 0.00% | 0.00 | Feb 15 | ||
Feb 20, 2013 | CHIEF FINANCIAL OFFICER | 0.00 | $14.55 | -$1.59M | SELL-OPTIONS | 0.00% | 8.50K | Feb 15 | ||
Feb 20, 2013 | DIRECTOR | -30.00K | $21.82 | -$654.60K | SELL | -3.70% | 781.08K | Feb 19 | ||
Dec 19, 2012 | DIRECTOR | -5.00K | $16.07 | -$76.55K | SELL | -2.47% | 197.71K | Dec 17 | ||
Jul 06, 2012 | — | 0.00 | $16.10 | -$643.29K | SELL-OPTIONS | 0.00% | 3.03K | Jul 05 | ||
Jul 03, 2012 | — | 0.00 | $15.55 | -$630.66K | SELL-OPTIONS | 0.00% | 3.03K | Jul 02 | ||
May 25, 2012 | DIRECTOR | -22.00K | $22.27 | -$445.40K | SELL | -2.61% | 821.08K | May 23 - May 24 | ||
May 18, 2012 | DIRECTOR | 0.00 | $15.11 | -$84.45K | SELL-OPTIONS | 0.00% | 100.00K | May 16 | ||
May 15, 2012 | EVP, HUMAN RESOURCES | 0.00 | $15.91 | -$2.16M | SELL-OPTIONS | 0.00% | 18.06K | May 11 | ||
May 15, 2012 | EVP, GENERAL COUNSEL | -815.00 | $19.60 | -$417.23K | SELL | -100.00% | 0.00 | May 14 | ||
May 08, 2012 | CHIEF EXECUTIVE OFFICER | 0.00 | $14.26 | -$3.73M | SELL-OPTIONS | 0.00% | 309.71K | May 07 | ||
May 01, 2012 | — | -13.98K | $22.70 | -$317.26K | SELL | -93.14% | 1.03K | May 01 | ||
May 01, 2012 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $15.86 | -$425.55K | SELL-OPTIONS | 0.00% | 0.00 | Apr 27 | ||
Feb 21, 2012 | DIRECTOR | -20.00K | $17.53 | -$350.66K | SELL | -2.46% | 793.08K | Feb 17 | ||
Jan 20, 2012 | DIRECTOR | 50.00K | $17.70 | $884.75K | BUY | 50.00% | 150.00K | Jan 18 - Jan 19 | ||
Jan 17, 2012 | DIRECTOR | 14.63K | $16.37 | $239.41K | BUY | 4.29% | 355.84K | Jan 12 - Jan 13 | ||
Jan 17, 2012 | DIRECTOR | 543.24K | $16.37 | $8.89M | BUY | 4.57% | 12.43M | Jan 12 - Jan 13 | ||
Dec 12, 2011 | DIRECTOR | 403.52K | $13.37 | $5.39M | BUY | 3.51% | 11.89M | Dec 08 - Dec 09 | ||
Dec 12, 2011 | DIRECTOR | 10.83K | $13.37 | $144.74K | BUY | 3.28% | 341.21K | Dec 08 - Dec 09 | ||
Dec 07, 2011 | DIRECTOR | 41.62K | $13.75 | $572.10K | BUY | 14.41% | 330.39K | Dec 05 - Dec 07 | ||
Dec 07, 2011 | DIRECTOR | 1.56M | $13.75 | $21.38M | BUY | 15.66% | 11.48M | Dec 05 - Dec 07 | ||
Dec 01, 2011 | DIRECTOR | 51.27K | $13.04 | $668.78K | BUY | 21.59% | 288.77K | Nov 29 - Dec 01 | ||
Dec 01, 2011 | DIRECTOR | 2.41M | $13.13 | $31.59M | BUY | 31.99% | 9.93M | Nov 29 - Dec 01 | ||
Nov 21, 2011 | DIRECTOR | 7.50K | $13.40 | $100.50K | BUY | ∞ | 7.50K | Nov 17 | ||
Jun 23, 2011 | — | 0.00 | $12.03 | -$525.99K | SELL-OPTIONS | 0.00% | 13.98K | Jun 21 | ||
Jun 17, 2011 | DIRECTOR | -20.00K | $18.02 | -$360.45K | SELL | -2.40% | 813.08K | Jun 16 - Jun 17 | ||
Jun 10, 2011 | CHIEF FINANCIAL OFFICER | 0.00 | $11.43 | -$1.26M | SELL-OPTIONS | 0.00% | 8.50K | Jun 09 | ||
May 19, 2011 | EVP, HUMAN RESOURCES | 0.00 | $16.55 | -$412.64K | SELL-OPTIONS | 0.00% | 18.06K | May 17 | ||
May 13, 2011 | DIRECTOR | -20.00K | $20.16 | -$403.12K | SELL | -2.34% | 833.08K | May 11 - May 12 | ||
May 11, 2011 | EVP, GENERAL COUNSEL | -100.00K | $10.73 | -$1.99M | SELL | -95.69% | 4.50K | May 09 - May 10 | ||
May 09, 2011 | DIRECTOR | -20.00K | $19.51 | -$390.21K | SELL | -2.29% | 853.08K | May 05 - May 09 | ||
May 09, 2011 | — | -5.34K | $19.55 | -$104.46K | SELL | -27.66% | 13.98K | May 06 | ||
Apr 13, 2011 | CHIEF DRUG DISCOVERY SCIENTIST | 0.00 | $11.44 | -$1.20M | SELL-OPTIONS | 0.00% | 66.50K | Apr 11 | ||
Apr 08, 2011 | EVP, GENERAL COUNSEL | 0.00 | $10.16 | -$1.27M | SELL-OPTIONS | 0.00% | 4.50K | Apr 07 | ||
Apr 08, 2011 | — | 0.00 | $10.06 | -$347.38K | SELL-OPTIONS | 0.00% | 11.32K | Apr 08 | ||
Apr 07, 2011 | DIRECTOR | -10.00K | $16.01 | -$160.15K | SELL | -1.13% | 873.08K | Apr 05 | ||
Mar 25, 2011 | DIRECTOR | -10.00K | $14.65 | -$146.53K | SELL | -1.12% | 883.08K | Mar 25 | ||
Mar 18, 2011 | CHIEF DRUG DISCOVERY SCIENTIST | 0.00 | $12.06 | -$927.33K | SELL-OPTIONS | 0.00% | 66.50K | Mar 16 - Mar 18 | ||
Feb 22, 2011 | CHIEF DRUG DISCOVERY SCIENTIST | 0.00 | $10.16 | -$419.00K | SELL-OPTIONS | 0.00% | 66.50K | Feb 17 | ||
Jan 20, 2011 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $11.25 | -$366.71K | SELL-OPTIONS | 0.00% | 0.00 | Jan 18 | ||
Dec 23, 2010 | DIRECTOR | -20.00K | $17.01 | -$340.23K | SELL | -2.18% | 896.08K | Dec 22 - Dec 23 | ||
Nov 18, 2010 | DIRECTOR | -11.00K | $15.99 | -$175.94K | SELL | -1.19% | 916.08K | Nov 16 - Nov 17 | ||
Oct 26, 2010 | DIRECTOR | -34.25K | $16.97 | -$581.25K | SELL | -3.56% | 927.08K | Oct 22 - Oct 25 | ||
Sep 23, 2010 | DIRECTOR | -32.15K | $14.88 | -$478.32K | SELL | -11.92% | 237.50K | Sep 21 - Sep 23 | ||
Sep 23, 2010 | DIRECTOR | -397.05K | $14.88 | -$5.91M | SELL | -11.92% | 2.93M | Sep 21 - Sep 23 | ||
Sep 23, 2010 | DIRECTOR | -32.39K | $14.88 | -$481.83K | SELL | -11.92% | 239.26K | Sep 21 - Sep 23 | ||
Sep 23, 2010 | DIRECTOR | -21.62K | $14.88 | -$321.68K | SELL | -11.92% | 159.74K | Sep 21 - Sep 23 | ||
Sep 23, 2010 | DIRECTOR | -1.02M | $14.88 | -$15.13M | SELL | -11.92% | 7.51M | Sep 21 - Sep 23 | ||
Aug 11, 2010 | DIRECTOR | -12.80K | $14.06 | -$180.07K | SELL | -4.50% | 271.65K | Aug 09 - Aug 10 | ||
Aug 11, 2010 | DIRECTOR | -8.55K | $14.06 | -$120.21K | SELL | -4.50% | 181.36K | Aug 09 - Aug 10 | ||
Aug 11, 2010 | DIRECTOR | -156.93K | $14.06 | -$2.21M | SELL | -4.50% | 3.33M | Aug 09 - Aug 10 | ||
Aug 11, 2010 | DIRECTOR | -401.87K | $14.06 | -$5.65M | SELL | -4.50% | 8.53M | Aug 09 - Aug 10 | ||
Aug 11, 2010 | DIRECTOR | -12.71K | $14.07 | -$178.70K | SELL | -4.50% | 269.65K | Aug 09 - Aug 10 | ||
Aug 10, 2010 | EVP, GENERAL COUNSEL | 0.00 | $10.02 | -$734.25K | SELL-OPTIONS | 0.00% | 4.50K | Aug 06 | ||
Aug 10, 2010 | — | -15.62K | $14.06 | -$219.53K | SELL | -74.51% | 5.34K | Aug 09 | ||
Jul 06, 2010 | CHIEF FINANCIAL OFFICER | 2.00K | $10.24 | $20.48K | BUY | 30.77% | 8.50K | Jul 01 | ||
Jul 06, 2010 | CHIEF EXECUTIVE OFFICER | 10.00K | $10.43 | $104.26K | BUY | 3.93% | 264.56K | Jul 01 | ||
Jun 21, 2010 | EVP, HUMAN RESOURCES | 0.00 | $9.60 | -$695.54K | SELL-OPTIONS | 0.00% | 0.00 | Jun 17 | ||
Mar 17, 2010 | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $8.56 | -$175.00K | SELL-OPTIONS | 0.00% | 0.00 | Mar 15 | ||
Jan 08, 2010 | EVP, BIOLOGY & PRECLINICAL DEV | -22.00K | $10.90 | -$239.80K | SELL | -36.58% | 38.14K | Jan 08 | ||
Mar 10, 2009 | CHIEF EXECUTIVE OFFICER | 20.00K | $2.10 | $42.00K | BUY | 8.53% | 254.56K | Mar 06 - Mar 09 | ||
Mar 05, 2009 | DIRECTOR | 162.00 | $2.15 | $347.96 | BUY | 0.12% | 139.62K | Mar 03 - Mar 05 | ||
Mar 05, 2009 | DIRECTOR | 3.45K | $2.15 | $7.40K | BUY | 0.10% | 3.49M | Mar 03 - Mar 05 | ||
Mar 05, 2009 | DIRECTOR | 10.00 | $2.15 | $21.50 | BUY | 0.00% | 284.45K | Mar 03 - Mar 05 | ||
Mar 05, 2009 | DIRECTOR | 20.76K | $2.15 | $44.63K | BUY | 0.29% | 7.08M | Mar 03 - Mar 05 | ||
Mar 05, 2009 | DIRECTOR | 576.00 | $2.15 | $1.24K | BUY | 0.32% | 180.85K | Mar 03 - Mar 05 | ||
Mar 05, 2009 | CHIEF EXECUTIVE OFFICER | 20.00K | $2.20 | $44.00K | BUY | 9.32% | 234.56K | Mar 03 - Mar 05 | ||
Mar 02, 2009 | DIRECTOR | 17.00 | $2.15 | $36.60 | BUY | 0.01% | 284.44K | Mar 02 | ||
Mar 02, 2009 | DIRECTOR | 343.00 | $2.15 | $738.46 | BUY | 0.25% | 139.45K | Mar 02 | ||
Mar 02, 2009 | DIRECTOR | 7.70K | $2.15 | $16.58K | BUY | 0.22% | 3.48M | Mar 02 | ||
Mar 02, 2009 | DIRECTOR | 927.00 | $2.15 | $2.00K | BUY | 0.52% | 180.27K | Mar 02 | ||
Mar 02, 2009 | DIRECTOR | 33.36K | $2.15 | $71.83K | BUY | 0.47% | 7.06M | Mar 02 | ||
Dec 19, 2008 | DIRECTOR | 227.27K | $3.50 | $796.55K | BUY | 7.00% | 3.48M | Dec 17 - Dec 19 | ||
Dec 19, 2008 | DIRECTOR | 1.90K | $3.55 | $6.73K | BUY | 0.67% | 285.48K | Dec 17 - Dec 19 | ||
Dec 19, 2008 | DIRECTOR | 5.06K | $3.51 | $17.73K | BUY | 3.77% | 139.11K | Dec 17 - Dec 19 | ||
Dec 19, 2008 | DIRECTOR | 735.33K | $3.51 | $2.58M | BUY | 11.69% | 7.03M | Dec 17 - Dec 19 | ||
Dec 19, 2008 | DIRECTOR | 20.09K | $3.51 | $70.41K | BUY | 12.61% | 179.34K | Dec 17 - Dec 19 | ||
Nov 24, 2008 | CHIEF DRUG DISCOVERY SCIENTIST | 5.00K | $2.19 | $10.95K | BUY | 11.15% | 49.84K | Nov 21 | ||
Nov 21, 2008 | — | 8.00K | $2.71 | $21.68K | BUY | 3200.00% | 8.25K | Nov 20 | ||
Nov 21, 2008 | CHIEF FINANCIAL OFFICER | 4.00K | $2.36 | $9.44K | BUY | 160.00% | 6.50K | Nov 20 | ||
Nov 21, 2008 | EVP, GENERAL COUNSEL | 2.50K | $2.44 | $6.10K | BUY | 125.00% | 4.50K | Nov 20 | ||
Nov 21, 2008 | CHIEF EXECUTIVE OFFICER | 13.00K | $2.55 | $33.15K | BUY | 6.45% | 214.56K | Nov 20 | ||
Oct 16, 2008 | CHIEF EXECUTIVE OFFICER | 10.00K | $4.95 | $49.51K | BUY | 5.22% | 201.56K | Oct 14 - Oct 15 | ||
Aug 05, 2008 | DIRECTOR | 201.65K | $9.00 | $1.81M | BUY | 6.62% | 3.25M | Jul 31 | ||
Aug 05, 2008 | DIRECTOR | 1.54K | $9.00 | $13.85K | BUY | 0.55% | 283.58K | Jul 31 | ||
Aug 05, 2008 | DIRECTOR | 864.09K | $9.00 | $7.78M | BUY | 15.92% | 6.29M | Jul 31 | ||
Aug 05, 2008 | DIRECTOR | 27.72K | $9.00 | $249.52K | BUY | 21.08% | 159.26K | Jul 31 | ||
Aug 05, 2008 | DIRECTOR | 5.00K | $9.00 | $44.97K | BUY | 3.87% | 134.05K | Jul 31 | ||
Jan 24, 2008 | DIRECTOR | 7.00 | $10.62 | $74.34 | BUY | 0.01% | 131.53K | Jan 22 | ||
Jan 24, 2008 | DIRECTOR | 223.00 | $10.62 | $2.37K | BUY | 0.00% | 5.43M | Jan 22 | ||
Jan 24, 2008 | DIRECTOR | 65.00 | $10.62 | $690.30 | BUY | 0.00% | 3.05M | Jan 22 | ||
Jan 24, 2008 | DIRECTOR | 4.00 | $10.62 | $42.48 | BUY | 0.00% | 129.06K | Jan 22 | ||
Jan 24, 2008 | DIRECTOR | 1.00 | $10.62 | $10.62 | BUY | 0.00% | 282.04K | Jan 22 | ||
Jan 16, 2008 | DIRECTOR | 94.00 | $10.99 | $1.03K | BUY | 0.03% | 282.04K | Jan 14 | ||
Jan 16, 2008 | DIRECTOR | 34.62K | $10.99 | $380.40K | BUY | 0.64% | 5.43M | Jan 14 | ||
Jan 16, 2008 | DIRECTOR | 1.10K | $10.99 | $12.10K | BUY | 0.84% | 131.53K | Jan 14 | ||
Jan 16, 2008 | DIRECTOR | 13.68K | $10.99 | $150.25K | BUY | 0.45% | 3.05M | Jan 14 | ||
Jan 16, 2008 | DIRECTOR | 723.00 | $10.99 | $7.94K | BUY | 0.56% | 129.05K | Jan 14 | ||
Jan 11, 2008 | DIRECTOR | 334.00 | $10.94 | $3.65K | BUY | 0.12% | 281.95K | Jan 09 - Jan 11 | ||
Jan 11, 2008 | DIRECTOR | 48.39K | $10.94 | $529.51K | BUY | 1.62% | 3.03M | Jan 09 - Jan 11 | ||
Jan 11, 2008 | DIRECTOR | 122.51K | $10.94 | $1.34M | BUY | 2.32% | 5.39M | Jan 09 - Jan 11 | ||
Jan 11, 2008 | DIRECTOR | 3.89K | $10.94 | $42.57K | BUY | 3.08% | 130.43K | Jan 09 - Jan 11 | ||
Jan 11, 2008 | DIRECTOR | 2.56K | $10.94 | $28.00K | BUY | 2.03% | 128.33K | Jan 09 - Jan 11 | ||
Jan 08, 2008 | DIRECTOR | 993.83K | $10.14 | $10.08M | BUY | 23.24% | 5.27M | Jan 04 - Jan 08 | ||
Jan 08, 2008 | DIRECTOR | 31.57K | $10.14 | $320.19K | BUY | 33.25% | 126.53K | Jan 04 - Jan 08 | ||
Jan 08, 2008 | DIRECTOR | 392.57K | $10.14 | $3.98M | BUY | 15.14% | 2.98M | Jan 04 - Jan 08 | ||
Jan 08, 2008 | DIRECTOR | 20.75K | $10.14 | $210.42K | BUY | 19.76% | 125.77K | Jan 04 - Jan 08 | ||
Jan 08, 2008 | DIRECTOR | 2.71K | $10.14 | $27.50K | BUY | 0.97% | 281.62K | Jan 04 - Jan 08 | ||
Dec 19, 2007 | DIRECTOR | 4.96K | $10.60 | $52.56K | BUY | 4.96% | 105.02K | Dec 17 - Dec 19 | ||
Dec 19, 2007 | DIRECTOR | 648.00 | $10.60 | $6.87K | BUY | 0.23% | 278.90K | Dec 17 - Dec 19 | ||
Dec 19, 2007 | DIRECTOR | 93.85K | $10.60 | $994.55K | BUY | 3.76% | 2.59M | Dec 17 - Dec 19 | ||
Dec 19, 2007 | DIRECTOR | 237.59K | $10.60 | $2.52M | BUY | 5.88% | 4.28M | Dec 17 - Dec 19 | ||
Dec 19, 2007 | DIRECTOR | 7.55K | $10.60 | $80.00K | BUY | 8.64% | 94.96K | Dec 17 - Dec 19 | ||
Dec 12, 2007 | DIRECTOR | 433.42K | $9.99 | $4.33M | BUY | 12.02% | 4.04M | Dec 10 - Dec 12 | ||
Dec 12, 2007 | DIRECTOR | 13.77K | $9.99 | $137.53K | BUY | 18.70% | 87.41K | Dec 10 - Dec 12 | ||
Dec 12, 2007 | DIRECTOR | 1.18K | $9.99 | $11.82K | BUY | 0.43% | 278.25K | Dec 10 - Dec 12 | ||
Dec 12, 2007 | DIRECTOR | 171.20K | $9.99 | $1.71M | BUY | 7.36% | 2.50M | Dec 10 - Dec 12 | ||
Dec 12, 2007 | DIRECTOR | 9.05K | $9.99 | $90.39K | BUY | 9.94% | 100.06K | Dec 10 - Dec 12 | ||
Dec 06, 2007 | DIRECTOR | 1.14K | $8.98 | $10.23K | BUY | 1.27% | 91.01K | Dec 04 | ||
Dec 06, 2007 | DIRECTOR | 19.59K | $8.98 | $175.98K | BUY | 0.85% | 2.33M | Dec 04 | ||
Dec 06, 2007 | DIRECTOR | 1.81K | $8.98 | $16.28K | BUY | 2.52% | 73.64K | Dec 04 | ||
Dec 06, 2007 | DIRECTOR | 57.30K | $8.98 | $514.68K | BUY | 1.61% | 3.61M | Dec 04 | ||
Dec 06, 2007 | DIRECTOR | 153.00 | $8.98 | $1.37K | BUY | 0.06% | 277.07K | Dec 04 | ||
Dec 03, 2007 | DIRECTOR | 17.13K | $8.68 | $148.70K | BUY | 0.75% | 2.31M | Nov 29 - Dec 03 | ||
Dec 03, 2007 | DIRECTOR | 3.04K | $8.68 | $26.41K | BUY | 4.42% | 71.83K | Nov 29 - Dec 03 | ||
Dec 03, 2007 | DIRECTOR | 96.31K | $8.68 | $836.04K | BUY | 2.79% | 3.55M | Nov 29 - Dec 03 | ||
Dec 03, 2007 | DIRECTOR | 258.00 | $8.68 | $2.24K | BUY | 0.09% | 276.92K | Nov 29 - Dec 03 | ||
Nov 28, 2007 | DIRECTOR | 1.10K | $8.11 | $8.94K | BUY | 0.40% | 276.66K | Nov 26 - Nov 28 | ||
Nov 28, 2007 | DIRECTOR | 73.26K | $8.11 | $594.06K | BUY | 3.30% | 2.29M | Nov 26 - Nov 28 | ||
Nov 28, 2007 | DIRECTOR | 411.94K | $8.11 | $3.34M | BUY | 13.55% | 3.45M | Nov 26 - Nov 28 | ||
Nov 28, 2007 | DIRECTOR | 13.02K | $8.11 | $105.57K | BUY | 23.34% | 68.79K | Nov 26 - Nov 28 | ||
Nov 21, 2007 | DIRECTOR | 70.74K | $8.18 | $579.01K | BUY | 3.30% | 2.22M | Nov 19 - Nov 21 | ||
Nov 21, 2007 | DIRECTOR | 278.91K | $8.17 | $2.28M | BUY | 10.10% | 3.04M | Nov 19 - Nov 21 | ||
Nov 21, 2007 | DIRECTOR | 8.81K | $8.17 | $72.00K | BUY | 18.77% | 55.77K | Nov 19 - Nov 21 | ||
Nov 21, 2007 | DIRECTOR | 747.00 | $8.17 | $6.10K | BUY | 0.27% | 275.56K | Nov 19 - Nov 21 | ||
Nov 21, 2007 | DIRECTOR | 318.00 | $8.22 | $2.62K | BUY | 0.36% | 89.87K | Nov 19 | ||
Nov 16, 2007 | DIRECTOR | 10.66K | $8.49 | $90.54K | BUY | 29.38% | 46.95K | Nov 14 - Nov 16 | ||
Nov 16, 2007 | DIRECTOR | 337.46K | $8.49 | $2.87M | BUY | 13.92% | 2.76M | Nov 14 - Nov 16 | ||
Nov 16, 2007 | DIRECTOR | 126.10K | $8.50 | $1.07M | BUY | 6.24% | 2.15M | Nov 14 - Nov 16 | ||
Nov 16, 2007 | DIRECTOR | 904.00 | $8.49 | $7.68K | BUY | 0.33% | 274.81K | Nov 14 - Nov 16 | ||
Nov 13, 2007 | DIRECTOR | 2.44K | $8.09 | $19.75K | BUY | 2.84% | 88.50K | Nov 09 - Nov 13 | ||
Nov 13, 2007 | DIRECTOR | 21.93K | $8.09 | $177.29K | BUY | 152.63% | 36.29K | Nov 09 - Nov 13 | ||
Nov 13, 2007 | DIRECTOR | 274.18K | $8.09 | $2.22M | BUY | 15.70% | 2.02M | Nov 09 - Nov 13 | ||
Nov 13, 2007 | DIRECTOR | 693.77K | $8.09 | $5.61M | BUY | 40.10% | 2.42M | Nov 09 - Nov 13 | ||
Nov 13, 2007 | DIRECTOR | 1.86K | $8.09 | $15.02K | BUY | 0.68% | 273.91K | Nov 09 - Nov 13 | ||
Aug 20, 2007 | CHIEF EXECUTIVE OFFICER | 16.66K | $5.47 | $91.16K | BUY | 9.53% | 191.56K | Aug 17 | ||
Aug 03, 2007 | DIRECTOR | 171.33K | $4.91 | $840.55K | BUY | 10.88% | 1.75M | Aug 01 - Aug 03 | ||
Aug 03, 2007 | DIRECTOR | 451.86K | $4.91 | $2.22M | BUY | 35.35% | 1.73M | Aug 01 - Aug 03 | ||
Aug 03, 2007 | DIRECTOR | 1.15K | $4.91 | $5.65K | BUY | 0.42% | 272.05K | Aug 01 - Aug 03 | ||
Aug 03, 2007 | DIRECTOR | 14.37K | $4.91 | $70.47K | BUY | ∞ | 14.37K | Aug 01 - Aug 03 | ||
Feb 13, 2007 | CHIEF DRUG DISCOVERY SCIENTIST | 5.00K | $3.88 | $19.42K | BUY | 17.92% | 32.91K | Apr 17 | ||
Apr 07, 2006 | EVP, HUMAN RESOURCES | 3.00K | $3.65 | $10.95K | BUY | 19.92% | 18.06K | Apr 06 | ||
Apr 05, 2006 | CHIEF EXECUTIVE OFFICER | 5.50K | $3.56 | $19.58K | BUY | 3.25% | 174.90K | Apr 04 | ||
Apr 05, 2006 | CHIEF FINANCIAL OFFICER | 2.50K | $3.60 | $9.00K | BUY | ∞ | 2.50K | Apr 04 | ||
Apr 05, 2006 | EVP, GENERAL COUNSEL | 2.00K | $3.59 | $7.18K | BUY | ∞ | 2.00K | Apr 04 | ||
Aug 23, 2005 | CHIEF EXECUTIVE OFFICER | 2.70K | $7.24 | $19.56K | BUY | 2.31% | 119.40K | Aug 23 | ||
Mar 10, 2005 | DIRECTOR | 20.00K | $7.05 | $140.95K | BUY | 400.00% | 25.00K | Mar 09 | ||
Nov 04, 2004 | DIRECTOR | 300.00K | $9.75 | $2.92M | BUY | ∞ | 30.94K | Nov 01 | ||
Sep 13, 2004 | DIRECTOR | 100.00K | $7.74 | $774.00K | BUY | 201.68% | 149.58K | Sep 09 | ||
Aug 17, 2004 | CHIEF EXECUTIVE OFFICER | 3.50K | $5.62 | $19.66K | BUY | 0.84% | 421.13K | Aug 16 | ||
Aug 13, 2004 | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 23.71% | 1.33M | Aug 12 | ||
Aug 13, 2004 | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 23.71% | 1.33M | Aug 12 | ||
Aug 13, 2004 | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 23.71% | 1.33M | Aug 12 | ||
Aug 13, 2004 | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 20.00% | 1.53M | Aug 12 | ||
Sep 24, 2003 | 10% OWNER | 13.80K | $4.97 | $68.59K | BUY | 5.53% | 263.50K | Sep 22 | ||
Sep 24, 2003 | 10% OWNER | 71.10K | $4.97 | $353.40K | BUY | 6.97% | 1.09M | Sep 22 | ||
Sep 24, 2003 | 10% OWNER | 67.30K | $4.97 | $334.51K | BUY | 4.76% | 1.48M | Sep 22 | ||
Sep 23, 2003 | 10% OWNER | 107.65K | $5.04 | $542.28K | BUY | 75.78% | 249.70K | Sep 19 | ||
Sep 23, 2003 | 10% OWNER | 526.00K | $5.04 | $2.65M | BUY | 59.31% | 1.41M | Sep 19 | ||
Sep 23, 2003 | 10% OWNER | 556.35K | $5.04 | $2.80M | BUY | 119.91% | 1.02M | Sep 19 |
FAQ
Est-ce que le trading d'initiés est légal ?
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Quels sont quelques exemples de manipulation de marché ?
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.
Parcourir transactions d'initiés sur toutes les actions.